CClinicalTrials.gg
Not yet recruitingNCT06825611Updated Mar 4, 2025

Detecting and Monitoring Scoliosis Without Radiography: Standard Radiographic Monitoring Program Versus Self-Screening with Momentum SpineTM

An interventional study of Momentum Application in Adolescent Idiopathic Scoliosis, sponsored by Children's Hospital Los Angeles. Not yet recruiting. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-03-04.

Sponsored by Children's Hospital Los Angeles · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
8 Years to 18 Years
Sex
All
01

Study summary

The goal of this clinical trial is for the Momentum SpineTM application to accurately detect scoliosis progression, including accuracy, margin of error, sensitivity, specificity, AUC, and overall agreement with radiographs in 8-18 year olds with adolescent idiopathic scoliosis. The main question it aims to answer [is/are]:

  • Based on previous data it is hypothesize that Momentum SpineTM imaging software will be able to accurately detect scoliosis progression (>= 7 degrees), including accuracy, margin of error, sensitivity, specificity, AUC, and overall agreement with radiographs.
  • Based on the above hypothesis that Momentum SpineTM is able to accurately detect scoliosis and curve progression (>= 7 degrees).
  • It is hypothesized there will be indications for accelerated clinical visits based on at home detection of progression, and that these visits will be accurate and necessary.
  • It is hypothesized that there will be a proportion of standard care visits that are deemed unnecessary, and that the application is able to accurately predict these visits.

Participants will:

  • Use Momentum SpineTM assessment from home to perform body scans at 1-month intervals on personal device and during the clinical visit.
  • Received monthly scans that will be evaluated by the provider using the application.
  • Receive additional scans as warranted.
  • Complete net promoter score (NPS) within the application following completion of a body scan.
  • Complete a patient satisfaction survey following 6 months of application usage.
02

Conditions studied

  • Adolescent Idiopathic Scoliosis

Browse trials for

Keywords

  • spinal curve monitoring
  • Scoliosis mobile application
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's planned enrollment of 100 is above the median of 44 across 344 interventional studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Children's Hospital Los Angeles is the lead sponsor of 150 studies on the registry; 46 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children between the ages of 8-18 years of age
  • Confirmed radiographic diagnosis of adolescent idiopathic scoliosis
  • No history of spinal/ chest surgery.
  • Participants who have had spine x-rays ±1 week as baseline visit at CHLA will be included in the study.
  • Participants who have identifiable markings such as tattoos or birthmarks can be included in the study, though their markings will be covered with tape.

Exclusion criteria

Exclusion Criteria:

  • Participants who have had x-rays in a brace will not be included.
  • Participants who have had an x-ray from another institution will not be included in the study. X-rays from out of community are typically done with a different and lower quality machine then the one at our institution. Additionally, we do not have consent from outside institutions to use their x-rays for research purposes.
  • Participants with a confirmed pregnancy will not be included. Pregnancy status will be self-reported by participants.
  • Participants with the existence of a second deformity which may affect topographic assessment will be excluded (e.g. Limb length discrepancy greater than 2cm).
  • Families who do not speak English and Spanish will be unable to participate as the application is only available in English and Spanish at this time.
  • Families who do not have access to their own compatible personal smart phone device will be unable to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Momentum Application

    Patients diagnosed with scoliosis between 8-18 years of age

    Device: Momentum Application

Interventions

  • DeviceMomentum Application

    A mobile application to scan and predict spinal curvature. The application monitors curvature and track changes over time.

06

What researchers measure

Primary outcomes

  1. Accuracy of Scoliosis Progression

    Progression will be defined as a change of greater than or equal to 7 degrees. The progression between the application will be compared to the radiographs done manually, with evaluation of the margin of error, sensitivity, specificity, AUC, and overall agreement with the radiographs.

    Time frame: Immediately from enrollment and monthly through study completion

Secondary outcomes

  1. Proportion of follow-up visits that were correctly accelerated

    Accelerated visits are defined as medical appointments less than 6 months apart (sooner than routine follow-up) suggested by the Momentum Spine mobile application. When Momentum Spine detects progression on 3D models obtained at home, it suggests the clinical team see that patient sooner than the planned semi-annual visit in order to implement treatments earlier (bracing, change in brace, etc.). This endpoint will calculate the percentage of accelerated visits suggested by Momentum Spine where scoliosis progression was present as well as where a change in treatment was required.

    Time frame: Immediately from enrollment through study completion, at an average of 2 years

  2. Necessity of visit

    Coronal curve magnitude between site-specific X-ray measurements and coronal curve magnitude predictions output by Momentum Spine will be compared . The cutoff to determine whether the predicted coronal curve magnitude will be a difference of +/- 7 degrees when compared to the average of the readings from x-rays. Progression noted via Momentum Spine and on radiographs will be compared. Necessary visit = Radiographic Progression \>7 degrees Unnecessary visit = Radiographic Progression \<7 degrees Percentage agreement between Radiographic and MS progression values, with a cutoff point of 7 degrees, will be assessed.

    Time frame: Immediately from enrollment and monthly through study completion

  3. Proportion of avoidable x-rays using Momentum Spine

    An avoidable x-ray is defined as the percentage of radiographs obtained as part of routine semi-annual follow-up that show an absence of scoliosis progression where Momentum Spine was in agreement. This metric demonstrates that Momentum Spine is an accurate tool for determining when spinal radiographs are necessary.

    Time frame: Immediately from enrollment and monthly through study completion

  4. Patient Satisfaction Survey

    The patient satisfaction survey consists of 6 open-ended questions to understand what the experience has been for the individual using the application.

    Time frame: Only at the 6 month visit

  5. Net Promoter Score

    The Net Promoter Score (NPS) is measured by collecting patient/parent ratings on a 0-10 scale in response to questions on how likely they would use the app. The data is collected via a survey embedded within the product. The score uses a scale between a minimum value of 0 (worst) to a maximum value of 5(best).

    Time frame: Immediately from enrollment and monthly through study completion

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06825611
Lead sponsor
Children's Hospital Los Angeles
Collaborators
Momentum Health Inc.
Responsible party
Lindsay Andras (Attending Physician, Children's Hospital Los Angeles) — Principal investigator
First posted
Feb 13, 2025
Start date
Mar 15, 2025 (estimated)
Primary completion
Aug 15, 2027 (estimated)
Completion
Aug 15, 2027 (estimated)
Last update
Mar 4, 2025

Study contacts

Tiffany Phan, BA
Contact
tphan@chla.usc.edu
3234612142
Lindsay M Andras, MD
Contact
landras@chla.usc.edu
323-361-2148
Lindsay M Andras, MD
principal investigator · Children's Hospital Los Angeles

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion